Literature DB >> 30025312

Orbitofrontal connectivity is associated with depression and anxiety in marijuana-using adolescents.

Punitha Subramaniam1, Jadwiga Rogowska2, Jennifer DiMuzio2, Melissa Lopez-Larson3, Erin McGlade4, Deborah Yurgelun-Todd5.   

Abstract

BACKGROUND: Prevalence of marijuana (MJ) use among adolescents has been on the rise. MJ use has been reported to impact several brain regions, including frontal regions such as the orbitofrontal cortex (OFC). The OFC is involved in emotion regulation and processing and has been associated with symptoms of depression and anxiety. Therefore, we hypothesized that adolescent MJ users would show disruptions in OFC connectivity compared with healthy adolescents (HC) which would be associated with symptoms of mood and anxiety.
METHODS: 43 MJ-using and 31 HC adolescents completed clinical measures including the Hamilton Anxiety Scale (HAM-A) and Hamilton Depression Rating Scale (HAM-D). Resting-state functional magnetic resonance imaging data was also acquired for all participants.
RESULTS: In MJ users, increased depressive symptoms were associated with increased connectivity between the left OFC and left parietal regions. In contrast, lower ratings of anxiety were associated with increased connectivity between right and left OFC and right occipital and temporal regions. These findings indicate significant differences in OFC connectivity in MJ-using adolescents, which correlated with mood/anxiety. LIMITATIONS: Future studies with an increased number of female participants is required to address potential sex differences in connectivity patterns related to symptoms of depression and anxiety.
CONCLUSIONS: This study highlights the association between OFC connectivity, MJ use, and symptoms of depression and anxiety in adolescents. These findings provide further insight into understanding the neural correlates that modulate the relationship between comorbid MJ use and mood disorders and could potentially help us better develop preventive and treatment measures.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adolescents; Anxiety; Depression; Marijuana; Orbitofrontal cortex; Resting-state fMRI

Mesh:

Year:  2018        PMID: 30025312     DOI: 10.1016/j.jad.2018.07.002

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  10 in total

Review 1.  Is resting-state functional connectivity altered in regular cannabis users? A systematic review of the literature.

Authors:  Hannah Thomson; Izelle Labuschagne; Lisa-Marie Greenwood; Emily Robinson; Hannah Sehl; Chao Suo; Valentina Lorenzetti
Journal:  Psychopharmacology (Berl)       Date:  2021-08-20       Impact factor: 4.530

2.  Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: evidence from 90 studies and 9441 participants.

Authors:  Sarah D Lichenstein; Nick Manco; Lora M Cope; Leslie Egbo; Kathleen A Garrison; Jillian Hardee; Ansel T Hillmer; Kristen Reeder; Elisa F Stern; Patrick Worhunsky; Sarah W Yip
Journal:  Neuropsychopharmacology       Date:  2021-11-27       Impact factor: 8.294

Review 3.  The associations of comorbid substance use disorders and psychiatric conditions with adolescent brain structure and function: A review.

Authors:  Danielle S Kroll; Dana E Feldman; Szu-Yung Ariel Wang; Rui Zhang; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  J Neurol Sci       Date:  2020-08-19       Impact factor: 3.181

4.  Neural and behavioral correlates associated with adolescent marijuana use.

Authors:  Punitha Subramaniam; Deborah Yurgelun-Todd
Journal:  Curr Addict Rep       Date:  2020-10-02

Review 5.  Balancing act: Neural correlates of affect dysregulation in youth depression and substance use - A systematic review of functional neuroimaging studies.

Authors:  Divyangana Rakesh; Nicholas B Allen; Sarah Whittle
Journal:  Dev Cogn Neurosci       Date:  2020-03-13       Impact factor: 6.464

Review 6.  Depression Onset in Long-term Adolescent Cannabinoid Use: A Neurobiological Review.

Authors:  Shawn Y Forrester; Nusrat Jahan
Journal:  Cureus       Date:  2020-04-21

7.  Transient effects of multi-infusion ketamine augmentation on treatment-resistant depressive symptoms in patients with treatment-resistant bipolar depression - An open-label three-week pilot study.

Authors:  Chuanjun Zhuo; Feng Ji; Hongjun Tian; Lina Wang; Feng Jia; Deguo Jiang; Ce Chen; Chunhua Zhou; Xiaodong Lin; Jingjing Zhu
Journal:  Brain Behav       Date:  2020-07-03       Impact factor: 2.708

8.  Functional brain connectomes reflect acute and chronic cannabis use.

Authors:  J G Ramaekers; N L Mason; S W Toennes; E L Theunissen; E Amico
Journal:  Sci Rep       Date:  2022-02-14       Impact factor: 4.379

9.  Resting-State Directional Connectivity and Anxiety and Depression Symptoms in Adult Cannabis Users.

Authors:  Liangsuo Ma; John M Hettema; Janna Cousijn; James M Bjork; Joel L Steinberg; Lori Keyser-Marcus; Kyle Woisard; QiQi Lu; Roxann Roberson-Nay; Antonio Abbate; F Gerard Moeller
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-10-07

10.  Adjunct ketamine treatment of depression in treatment-resistant schizophrenia patients is unsatisfactory in pilot and secondary follow-up studies.

Authors:  Chuanjun Zhuo; Xiaodong Lin; Hongjun Tian; Sha Liu; Haiman Bian; Ce Chen
Journal:  Brain Behav       Date:  2020-03-15       Impact factor: 2.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.